State Street’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

State Street’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-24,400	Closed	-$14K	–	3753
2016 Q3	$14K	Hold	24,400	–	–	﹤0.01%	3558
2016 Q2	$15K	Sell	24,400 -823,792	-97%	-$879K	﹤0.01%	3676
2016 Q1	$1.24M	Buy	848,192 +155,708	+22%	+$307K	﹤0.01%	3167
2015 Q4	$2.21M	Sell	692,484 -1,523	-0.2%	-$7.32K	﹤0.01%	2960
2015 Q3	$4.34M	Buy	694,007 +96,467	+16%	+$902K	﹤0.01%	2591
2015 Q2	$5.94M	Buy	597,540 +121,992	+26%	+$1.07M	﹤0.01%	2544
2015 Q1	$3.51M	Buy	475,548 +79,045	+20%	+$532K	﹤0.01%	2764
2014 Q4	$2.12M	Buy	396,503 +53,860	+16%	+$276K	﹤0.01%	3019
2014 Q3	$1.73M	Buy	342,643 +14,698	+4%	+$90.3K	﹤0.01%	3082
2014 Q2	$2.2M	Buy	327,945 +315,345	+2,503%	+$2.01M	﹤0.01%	3027
2014 Q1	$91K	Buy	12,600 +600	+5%	+$3.56K	﹤0.01%	3508
2013 Q4	$45K	Hold	12,000	–	–	﹤0.01%	3545
2013 Q3	$40K	Hold	12,000	–	–	﹤0.01%	3545
2013 Q2	$40K	Buy	+12,000	New	+$43.5K	﹤0.01%	3468

Other funds holding NWBO

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

CDH

Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

MBT

Montecito Bank & Trust Santa Barbara, California $668M AUM 24.84% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street's NWBO Position: Q4 2016 in Review

State Street sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 24,400 shares — an estimated $14K sold.

State Street first reported a position in NWBO in Q2 2013 and held it in 14 quarters. The position peaked at $5.94M in Q2 2015. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

State Street reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
State Street sold 24,400 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $14K.
State Street first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 14 quarters.
State Street's Northwest Biotherapeutics, Inc. Common stock position peaked at $5.94M in Q2 2015.
8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on State Street's 13F filing for Q4 2016, filed 9 Feb 2017.